Los Angeles biotech firm Pelage Pharmaceuticals raises a $120 million Series B round co-led by ARCH Venture Partners and ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...

This new imaging technique, when applied to humans, could both improve our understanding of the circulatory system (veins, ...

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

In her album West End Girl, Lily Allen got candid about where her open relationship with ex-husband David Harbour went wrong ...

FRANKFURT, Germany, Oct. 28, 2025 /PRNewswire/ -- The Taiwan Traditional Chinese Medicine (TCM) Pavilion at CPHI Frankfurt 2025 (October 28–30) opened to strong international interest, attracting ...

Bioatla, Inc. (($BCAB)) announced an update on their ongoing clinical study. BioAtla, Inc. is conducting a Phase 1 clinical study titled An ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third ...

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, ...